Abstract
Purpose
To evaluate the hemostatic effects of transarterial infusion chemotherapy in addition to embolization (chemoembolization) for advanced primary lung cancer with tumor-related hemoptysis.
Materials and methods
Ten consecutive patients with stage IIIB/IV or recurrent primary lung cancer (squamous cell carcinoma in six, adenocarcinoma in four) who underwent chemoembolization for control of hemoptysis were enrolled. At enrollment, five patients were considered refractory and five had contraindications to standard therapies. The amount of hemoptysis was massive in two patients, moderate in seven, and slight in one. Transarterial infusion chemotherapy via feeding arteries using cisplatin (25 mg/m2) and 5-fluorouracil (300 mg/m2) was repeated every 3–4 weeks for three cycles. HepaSphere (100–150 µm) or gelatin sponge particles were selected as embolic materials depending on the presence of pulmonary shunts and were added for embolization just after drug infusion.
Results
Hemoptysis improved in all patients (resolution in nine, significant decrease in one). The median hemostasis time was 11.9 months (range 2.7–25.9 months). The target pulmonary lesions shrank in seven patients, and pulmonary atelectasis disappeared in three of five patients.
Conclusions
Chemoembolization may be a palliative option with favorable hemostasis time for advanced primary lung cancer with hemoptysis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Masuda E, Sista AK, Pua BB, Madoff DC. Palliative procedures in lung cancer. Semin Interv Radiol. 2013;30:199–205.
Kalva SP. Bronchial artery embolization. Tech Vasc Interv Radiol. 2009;12:130–8.
Chun JY, Morgan R, Belli AM. Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization. Cardiovasc Interv Radiol. 2010;33:240–50.
Hayakawa K, Tanaka F, Torizuka T, Mitsumori M, Okuno Y, Matsui A, et al. Bronchial artery embolization for hemoptysis: immediate and long-term results. Cardiovasc Interv Radiol. 1992;15:154–8.
Park HS, Kim YI, Kim HY, Zo JI, Lee JH, Lee JS. Bronchial artery and systemic artery embolization in the management of primary lung cancer patients with hemoptysis. Cardiovasc Interv Radiol. 2007;30:638–43.
Wang GR, Ensor JE, Gupta S, Hicks ME, Tam AL. Bronchial artery embolization for the management of hemoptysis in oncology patients: utility and prognostic factors. J Vasc Interv Radiol. 2009;20:722–9.
Garcia-Olivé I, Sanz-Santos J, Centeno C, Andreo F, Munoz-Ferrer Serra P, et al. Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm. J Vasc Interv Radiol. 2014;25:221–8.
Fujita T, Tanabe M, Moritani K, Matsunaga N, Matsumoto T. Immediate and late outcomes of bronchial and systemic artery embolization for palliative treatment of patients with nonsmall-cell lung cancer having hemoptysis. Am J Hosp Palliat Care. 2014;31:602–7.
Mehta AS, Ahmed O, Jilani D, Zangan S, Lorenz J, Funaki B, et al. Bronchial artery embolization for malignant hemoptysis: a single institutional experience. J Thorac Dis. 2015;7:1406–13.
Nakanishi M, Yoshida Y, Natazuka T. Prospective study of transarterial infusion of docetaxel and cisplatin to treat non-small-cell lung cancer in patients contraindicated for standard chemotherapy. Lung Cancer. 2012;77:353–8.
Seki A, Hori S, Sueyoshi S, Hori A, Kono M, Murata S, et al. Transcatheter arterial embolization with spherical embolic agent for pulmonary metastases from renal cell carcinoma. Cardiovasc Interv Radiol. 2013;36:1527–35.
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–16.
Vogl TJ, Lehnert T, Zangos S, Eichler K, Hammerstingl R, Korkusuz H, et al. Transpulmonary chemoembolization (TPCE) as a treatment for unresectable lung metastases. Eur Radiol. 2008;18:2449–55.
Tanaka N, Yamakado K, Murashima S, Takeda K, Matsumura K, Nakagawa T, et al. Superselective bronchial artery embolization for hemoptysis with a coaxial microcatheter system. J Vasc Interv Radiol. 1997;8:65–70.
White RI Jr. Bronchial artery embolotherapy for control of acute hemoptysis: analysis of outcome. Chest. 1999;115:912–5.
Chang J, Zhou L, Wang S, Clifford Chao KS. Panoramic cone beam computed tomography. Med Phys. 2012;39:2930–46.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Seki, A., Shimono, C. Transarterial chemoembolization for management of hemoptysis: initial experience in advanced primary lung cancer patients. Jpn J Radiol 35, 495–504 (2017). https://doi.org/10.1007/s11604-017-0659-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-017-0659-2